Opioid tapering trial shows promise for chronic pain patients
NCT ID NCT03485430
First seen Apr 25, 2026 · Last updated Jun 19, 2026 · Updated 5 times
Summary
This study looked at whether people with chronic non-cancer pain who take opioids daily can slowly reduce their dose without worsening pain or quality of life. 140 participants were split into two groups: one started tapering right away, the other waited 4 months. Researchers tracked pain levels, opioid use, and well-being over a year to see if tapering is safe and effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Lund University Hospital
Lund, Skåne County, 22100, Sweden
-
Pain and rehabilitation centre Linköping University Hospital
Linköping, Östergötland County, Sweden
-
Paincentre Sahlgrenska University Hospital
Gothenburg, Västra Götaland County, Sweden
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.